| Newton Wellesley Eye Associates Pc | |
| 2000 Washington St, Ste 462, Newton, Massachusetts 02462 | |
| (617) 964-1050 |
| Name | Newton Wellesley Eye Associates Pc |
|---|---|
| Organization Name | Newton Wellesley Eye Associates Pc |
| Location | 2000 Washington St, Ste 462, Newton, Massachusetts 02462 |
| Type | Supplier |
| Phone | (617) 964-1050 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
Roche and Ghent University (Belgium) have signed an agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer research projects in Ghent. Studies include multigene expression signature profiling on cancer research samples and, digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment of the first patient in a Phase 2 study with CXA-201. This multicenter, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active comparator in patients with complicated intra-abdominal Infections (cIAI). This international study is expected to enroll 120 patients.
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
› Verified 3 days ago
News Archive
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
Roche and Ghent University (Belgium) have signed an agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer research projects in Ghent. Studies include multigene expression signature profiling on cancer research samples and, digital PCR for sensitive detection of mutant cancer cells in a background of normal cells.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment of the first patient in a Phase 2 study with CXA-201. This multicenter, double-blind, randomized, study will compare the safety and efficacy of intravenous CXA-201 with an active comparator in patients with complicated intra-abdominal Infections (cIAI). This international study is expected to enroll 120 patients.
A study from Columbia University reveals that patients, who have been successfully treated with buprenorphine for opioid addiction, are at a greater risk of overdose after completion of the treatment. The study was titled, "Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder", and was published in the latest issue of The American Journal of Psychiatry. This study was funded and supported by the National Institute on Drug Abuse (NIDA) and the Agency for Healthcare Research and Quality.
› Verified 3 days ago
Amber Specialty Pharmacy Type: Medicare Supplier Location: 300 Washington St, Newton, Massachusetts 02458 Phone: (888) 370-1724 | |
Cvs Pharmacy #01858 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1199 1201 Center St, Newton, Massachusetts 02459 Phone: (617) 332-4900 | |
Cvs Pharmacy #06505 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 978 Boylston St, Newton, Massachusetts 02461 Phone: (617) 244-0821 | |
Newton Wellesley Eye Associates Pc Type: Medicare Supplier Location: 2000 Washington St, Newton, Massachusetts 02462 Phone: (617) 964-1050 | |
Next Step Bionics And Prosthetics, Type: Prosthetic/Orthotic Supplier Location: 57 Chapel St, Newton, Massachusetts 02458 Phone: (617) 581-6750 |